Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease.
Hay JW, Yu WM, Ashraf T. Hay JW, et al. Among authors: ashraf t. Pharmacoeconomics. 1999 Jan;15(1):47-74. doi: 10.2165/00019053-199915010-00004. Pharmacoeconomics. 1999. PMID: 10345158 Review.
Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.
Burckel E, Ashraf T, de Sousa Filho JP, Forleo Neto E, Guarino H, Yauti C, Barreto F de B, Champion L. Burckel E, et al. Among authors: ashraf t. Pharmacoeconomics. 1999 Nov;16(5 Pt 2):563-76. doi: 10.2165/00019053-199916050-00012. Pharmacoeconomics. 1999. PMID: 10662481 Clinical Trial.
Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agents.
Haffner SM, Ashraf T. Haffner SM, et al. Among authors: ashraf t. Manag Care Interface. 2000 Mar;13(3):52-8. Manag Care Interface. 2000. PMID: 11066277
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
Ashraf T, Hay JW, Pitt B, Wittels E, Crouse J, Davidson M, Furberg CD, Radican L. Ashraf T, et al. Am J Cardiol. 1996 Aug 15;78(4):409-14. doi: 10.1016/s0002-9149(96)00328-1. Am J Cardiol. 1996. PMID: 8752184
Methodology issues in lipid pharmacoeconomic investigations. Reactor panel and open forum.
Schwartz JS, McGuire A, Ashraf T, Otten N. Schwartz JS, et al. Among authors: ashraf t. Value Health. 1998 Sep;1(3):195-200. doi: 10.1046/j.1524-4733.1998.130195.x. Value Health. 1998. PMID: 16674352 No abstract available.
Lipid-lowering pharmacoeconomic studies. Reactor panel and open forum.
McGhan WF, McGuire A, Ashraf T, Schwartz JS. McGhan WF, et al. Among authors: ashraf t. Value Health. 1998 Sep;1(3):167-70. doi: 10.1046/j.1524-4733.1998.130167.x. Value Health. 1998. PMID: 16674347 No abstract available.
Commentary on Langley and McKenney Papers.
Ashraf T, Langley PC, Hay JW, Bonnette J, McKenney JM. Ashraf T, et al. Value Health. 1998 Nov;1(4):216-7. doi: 10.1046/j.1524-4733.1998.140216.x. Value Health. 1998. PMID: 16674542 No abstract available.
Managed care research participation and interests.
Ashraf T, Yeager M, Provost DG, Villeponteaux E. Ashraf T, et al. Manag Care Interface. 1998 Apr;11(4):65-70, 84. Manag Care Interface. 1998. PMID: 10181547
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection.
Simpson KN, Luo MP, Chumney E, Sun E, Brun S, Ashraf T. Simpson KN, et al. Among authors: ashraf t. HIV Clin Trials. 2004 Sep-Oct;5(5):294-304. doi: 10.1310/WT81-MEM4-5C4L-CHPK. HIV Clin Trials. 2004. PMID: 15562370
Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States.
Ashraf T, Arnold SB, Maxfield M Jr. Ashraf T, et al. J Reprod Med. 1994 Oct;39(10):791-8. J Reprod Med. 1994. PMID: 7837126
117 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback